Which of the following agents can be used as a local anesthetic for infiltration if a patient has a documented allergy to both amide and ester anesthetic derivatives?
Adrenaline is added to lignocaine to prolong its effect and decrease its absorption into the bloodstream in which ratio?
Which is the most commonly used local anesthetic?
Which of the following mixtures of anesthetics is applied topically on the skin?
Which of the following substances can cause allergic reactions when present in local anesthetics?
Which of the following is an advantage of adding adrenaline to lignocaine for local anesthetic injection?
Local anesthesia acts by which mechanism?
Which is the shortest acting local anesthetic agent?
If a patient has an absolute allergy to local anesthetics (LA), which drug is typically used as an alternative?
All of the following side effects can occur as a result of systemic absorption of lidocaine except?
Explanation: **Explanation:** **1. Why Diphenhydramine is correct:** In rare cases where a patient is allergic to both **Amides** (e.g., Lidocaine) and **Esters** (e.g., Procaine), **Diphenhydramine**, a first-generation H1-receptor antagonist, serves as an effective alternative for infiltration anesthesia. It possesses significant local anesthetic properties due to its ability to block sodium channels, similar to the mechanism of conventional local anesthetics. While it has a slower onset and shorter duration than lidocaine, it provides sufficient anesthesia for minor procedures (like suturing or biopsies) without cross-reactivity to traditional anesthetic classes. **2. Why other options are incorrect:** * **Nitrous oxide (A):** This is an inhalational anesthetic used for general anesthesia or conscious sedation. It provides systemic analgesia but has no local anesthetic effect when infiltrated into tissues. * **Bupivacaine (B):** This is a potent, long-acting **Amide** local anesthetic. If a patient is allergic to amides, bupivacaine is strictly contraindicated. * **Phenylephrine (C):** This is a selective alpha-1 adrenergic agonist. In local anesthesia, it (or epinephrine) is used as a vasoconstrictor to prolong the duration of action and reduce systemic toxicity, but it does not possess anesthetic properties itself. **3. Clinical Pearls for NEET-PG:** * **Chemical Distinction:** Amides have two "i"s in their name (L**i**doca**i**ne, Bup**i**vaca**i**ne), while Esters have only one (Procaine, Benzocaine). * **Allergy Profile:** True allergies to amides are extremely rare; most reactions are due to the preservative **methylparaben**. Esters are more commonly associated with allergies due to their metabolite, **Para-aminobenzoic acid (PABA)**. * **Concentration:** When using Diphenhydramine for local anesthesia, a **1% concentration** is typically used. Higher concentrations may cause skin necrosis.
Explanation: **Explanation:** The addition of **Adrenaline (Epinephrine)** to local anesthetics like Lignocaine serves as a vasoconstrictor. By constricting local blood vessels, it reduces the rate of systemic absorption, which achieves two primary goals: it **prolongs the duration of anesthesia** and **decreases systemic toxicity** (LAST). **Why 1:200,000 is the Correct Answer:** The standard, most widely accepted concentration for infiltration and nerve blocks is **1:200,000 (5 µg/mL)**. This ratio provides an optimal balance between effective local vasoconstriction and minimal systemic side effects (such as tachycardia or hypertension). It is the concentration found in commercially available "Lignocaine with Adrenaline" vials. **Analysis of Incorrect Options:** * **1:50,000 (A) and 1:100,000 (B):** These are higher concentrations of adrenaline. While sometimes used in dental procedures or specific plastic surgeries to achieve intense local hemostasis, they carry a significantly higher risk of tissue ischemia and systemic cardiovascular stimulation. * **1:500,000 (D):** This concentration is generally too dilute to provide effective, reliable prolongation of the anesthetic block in standard clinical practice. **High-Yield Clinical Pearls for NEET-PG:** * **Maximum Dose:** The maximum dose of Lignocaine increases from **3 mg/kg** (plain) to **7 mg/kg** when combined with Adrenaline. * **Contraindications:** Avoid using adrenaline-containing solutions in areas supplied by **end-arteries** (e.g., fingers, toes, tip of the nose, penis, and earlobes) due to the risk of gangrene. * **Adrenaline Benefits:** It also serves as a "marker" for accidental intravascular injection; a sudden rise in heart rate (>20 bpm) after injection suggests the needle is in a vessel.
Explanation: **Explanation:** **Bupivacaine** is the most commonly used local anesthetic (LA) in clinical practice today, particularly for regional anesthesia. Its popularity stems from its **high potency** and **prolonged duration of action** (3–6 hours). It is the "gold standard" for spinal anesthesia and is extensively used for epidural blocks and peripheral nerve blocks. Its unique property of **sensory-motor dissociation** (providing significant sensory block with less motor block at lower concentrations) makes it ideal for labor analgesia and post-operative pain management. **Analysis of Incorrect Options:** * **A. Dibucaine:** It is an amide LA but is rarely used clinically due to high toxicity. Its primary importance in NEET-PG is the **"Dibucaine Number,"** used to detect atypical pseudocholinesterase deficiency. * **C. Prilocaine:** While it has a fast onset, it is less commonly used because its metabolite (o-toluidine) can cause **methemoglobinemia**. It is primarily used in EMLA cream. * **D. Tetracaine:** An ester-type LA with a long duration of action. It was previously popular for spinal anesthesia but has largely been replaced by Bupivacaine due to a higher risk of systemic toxicity and technical handling issues. **High-Yield Clinical Pearls for NEET-PG:** * **Cardiotoxicity:** Bupivacaine is the most cardiotoxic LA. It binds tightly to sodium channels in the myocardium ("fast-in, slow-out" kinetics), leading to refractory arrhythmias. * **Antidote:** Intravenous **Lipid Emulsion (20% Intralipid)** is the specific treatment for Local Anesthetic Systemic Toxicity (LAST). * **Levobupivacaine/Ropivacaine:** These are the S-enantiomers of bupivacaine, developed to provide similar efficacy with a lower risk of cardiotoxicity.
Explanation: **Explanation:** The correct answer is **Lidocaine and prilocaine**. This specific combination is known as **EMLA (Eutectic Mixture of Local Anesthetics)**. **Why Lidocaine and Prilocaine?** A "eutectic mixture" is a combination of two substances that, when mixed in a specific ratio (in this case, 1:1), results in a melting point lower than that of either individual component. While lidocaine and prilocaine are solids at room temperature, their mixture becomes a **liquid oil**. This allows for a much higher concentration of the anesthetic base to penetrate the intact keratinized skin, providing effective topical anesthesia for procedures like venipuncture, skin grafting, or minor superficial surgeries. **Analysis of Incorrect Options:** * **B, C, and D:** While these drugs are common local anesthetics, they do not form a eutectic mixture suitable for topical skin penetration when combined. * **Bupivacaine** is primarily used for infiltration, nerve blocks, and spinal anesthesia due to its long duration of action. * **Procaine** is an ester-type anesthetic with poor skin penetration and is rarely used topically. **High-Yield Clinical Pearls for NEET-PG:** * **Composition:** EMLA contains 2.5% Lidocaine and 2.5% Prilocaine. * **Application:** It must be applied under an **occlusive dressing** for at least **45–60 minutes** to achieve adequate dermal analgesia. * **Side Effects:** A classic side effect of Prilocaine (and its metabolite o-toluidine) is **Methemoglobinemia**. * **Contraindications:** EMLA should not be used on mucous membranes, broken skin, or in infants under 12 months receiving methemoglobin-inducing drugs (e.g., sulfonamides).
Explanation: **Explanation:** True allergic reactions to local anesthetics (LAs) are rare (<1%), but when they occur, they are often triggered by additives or contaminants rather than the anesthetic agent itself. * **Methylparaben:** This is a preservative used in multi-dose vials of LAs to prevent bacterial growth. It is chemically related to **Para-aminobenzoic acid (PABA)**, a metabolite of ester-group LAs. Patients sensitized to PABA or ester LAs may develop Type IV (delayed) or Type I (immediate) hypersensitivity reactions to methylparaben. * **Sodium Metabisulfite:** This is an antioxidant added specifically to LA solutions containing **epinephrine** (vasoconstrictors) to prevent the oxidation of the catecholamine. It can trigger hypersensitivity, particularly in asthmatic patients, leading to bronchospasm. * **Latex:** While not a chemical additive, latex allergy can occur due to the **rubber stoppers** of the LA vials or the plungers of syringes. This is a significant cause of perioperative anaphylaxis. **Why "All of the above" is correct:** All three substances are documented triggers for allergic reactions in the context of local anesthesia administration. **High-Yield Clinical Pearls for NEET-PG:** 1. **Amides vs. Esters:** Ester LAs (e.g., Procaine, Benzocaine) are more likely to cause allergies because they are metabolized to PABA. Amide LAs (e.g., Lignocaine, Bupivacaine) are extremely rare causes of true allergy. 2. **Preservative-Free (PF) Solutions:** To avoid reactions, use "Preservative-Free" LAs (usually single-dose vials) which lack methylparaben and metabisulfite. 3. **Cross-Reactivity:** There is no cross-reactivity between the Ester and Amide groups. If a patient is allergic to an Ester, an Amide can safely be used.
Explanation: **Explanation:** The addition of **Adrenaline (Epinephrine)** to local anesthetics like Lignocaine is a classic pharmacological strategy based on its **vasoconstrictive properties** (via $\alpha_1$ receptors). 1. **Prolonged Duration of Action (Option C):** By causing local vasoconstriction, adrenaline reduces the rate of drug removal from the injection site by the bloodstream. This keeps the Lignocaine in contact with the nerve fibers for a longer period, significantly extending the duration of anesthesia. 2. **Decreased Systemic Toxicity (Option A):** Slower absorption into the systemic circulation results in lower peak plasma concentrations of the anesthetic. This reduces the risk of systemic side effects, particularly Central Nervous System (CNS) and Cardiovascular toxicity. 3. **Higher Permissible Doses (Option B):** Because systemic absorption is delayed, the body can metabolize the drug more effectively as it enters the blood slowly. This allows the clinician to safely administer a higher total dose. For Lignocaine, the maximum dose increases from **3 mg/kg (plain)** to **7 mg/kg (with adrenaline)**. **High-Yield Clinical Pearls for NEET-PG:** * **Concentration:** Adrenaline is typically added in a concentration of **1:200,000** (5 µg/mL). * **Contraindications:** Never use adrenaline-containing local anesthetics in areas supplied by **end-arteries** (e.g., fingers, toes, tip of the nose, ears, and penis) due to the risk of ischemia and gangrene. * **pH Effect:** Adrenaline is stable only in acidic solutions. Adding it lowers the pH of the anesthetic solution, which may increase the "sting" upon injection. * **Marker of Intravascular Injection:** Adrenaline acts as a marker; if accidentally injected into a vessel, it causes immediate tachycardia and hypertension, alerting the anesthesiologist.
Explanation: **Mechanism of Action:** Local anesthetics (LAs) primarily act by **blocking voltage-gated sodium (Na+) channels** on the internal surface of the nerve membrane. They exist in an equilibrium between an uncharged (lipid-soluble) base and a charged (water-soluble) cation. The uncharged base diffuses across the axonal membrane and re-ionizes inside the cell. This charged cation then binds to the **S6 segment of Domain IV** of the alpha-subunit of the Na+ channel. This binding prevents the influx of sodium ions, inhibiting depolarization and the subsequent propagation of the action potential (conduction blockade). **Analysis of Options:** * **A (Correct):** Na+ channel inhibition is the definitive mechanism. By preventing the rapid rise of the action potential, the threshold for excitation is never reached. * **B (Incorrect):** While some LAs may have weak secondary effects on Calcium channels (contributing to cardiotoxicity), it is not their primary mechanism for anesthesia. * **C (Incorrect):** Magnesium acts as a physiological NMDA receptor antagonist and can potentiate LAs, but LAs do not work by inhibiting Mg++ channels. * **D (Incorrect):** K+ channel inhibition would prolong repolarization rather than block the initiation of an impulse. **High-Yield Clinical Pearls for NEET-PG:** 1. **State-Dependent Block:** LAs have a higher affinity for channels in the **activated (open)** or **inactivated** states rather than the resting state. This is why rapidly firing nerves are blocked faster (use-dependent block). 2. **Order of Blockade:** Small myelinated fibers (B and A-delta) are blocked before unmyelinated C fibers. Clinically, the sequence is: **Autonomic > Pain > Temperature > Touch > Pressure > Motor.** 3. **Effect of pH:** LAs are weak bases. In **acidic environments (e.g., infected tissue/pus)**, more drug remains in the ionized form, which cannot cross the lipid membrane, leading to reduced efficacy. 4. **Sensitivity:** The **Nodes of Ranvier** are the primary site of action in myelinated nerves; at least three successive nodes must be blocked to interrupt conduction.
Explanation: **Explanation:** The duration of action of a local anesthetic (LA) is primarily determined by its **protein binding capacity** and **lipid solubility**. Agents with low protein binding are released from the sodium channels more quickly and are redistributed faster, leading to a shorter duration of action. **Procaine (Option A)** is an ester-linked local anesthetic with very low lipid solubility and minimal protein binding. It is rapidly hydrolyzed by plasma pseudocholinesterase, resulting in a very short duration of action (typically **30–60 minutes**). This makes it the shortest-acting agent among the options provided. **Analysis of Incorrect Options:** * **Lidocaine (Option B):** An amide-linked LA with intermediate lipid solubility and protein binding. It has an intermediate duration of action (**60–120 minutes**). * **Tetracaine (Option C):** An ester-linked LA, but unlike procaine, it is highly lipid-soluble and potent, leading to a long duration of action (**2–3 hours**). * **Bupivacaine (Option D):** An amide-linked LA with very high protein binding (approx. 95%). It is a long-acting agent (**3–6 hours**) commonly used for labor analgesia and post-operative pain. **High-Yield Clinical Pearls for NEET-PG:** * **Shortest acting:** Procaine (Ester) / Chloroprocaine (often cited as the absolute shortest due to rapid metabolism). * **Longest acting:** Bupivacaine, Ropivacaine, Etidocaine. * **Potency & Duration:** Correlate with **Lipid Solubility** and **Protein Binding** respectively. * **Onset of Action:** Correlates with **pKa** (lower pKa = faster onset, as more drug exists in the uncharged base form to cross the nerve membrane). Lidocaine has a faster onset than Bupivacaine.
Explanation: **Explanation:** **1. Why Diphenhydramine is the Correct Answer:** True absolute allergy to local anesthetics (LA) is rare, but when it occurs (typically to the ester group or preservatives like methylparaben), **Diphenhydramine hydrochloride** (an H1-receptor antagonist) is the preferred alternative. It possesses significant local anesthetic properties due to its ability to block sodium channels, similar to the mechanism of conventional LAs. When used in a 1% concentration, it provides sufficient surgical anesthesia for minor procedures (e.g., skin biopsy or laceration repair) with an onset of 5–10 minutes and a duration of approximately 30–60 minutes. **2. Analysis of Incorrect Options:** * **A. Chlorpheniramine maleate:** While also an antihistamine, it lacks the potent sodium-channel-blocking activity required to produce reliable surgical anesthesia. * **B. Benzalkonium chloride:** This is a quaternary ammonium antiseptic and preservative. It is not an anesthetic and can be neurotoxic if injected neuraxially. * **C. Ketamine hydrochloride:** While ketamine has some local anesthetic-like effects when applied topically or neuraxially, it is primarily used for systemic induction or dissociation. It is not the standard clinical substitute for infiltration in the context of LA allergy. **3. High-Yield Clinical Pearls for NEET-PG:** * **Allergy Classification:** Most LA allergies are to **Esters** (metabolized to PABA). **Amides** (e.g., Lidocaine) rarely cause true IgE-mediated reactions. * **Cross-Reactivity:** There is no cross-reactivity between the Ester and Amide groups. If a patient is allergic to Procaine (Ester), Lidocaine (Amide) can usually be used. * **Preservative Issue:** Often, the "allergy" is actually to **Methylparaben** (a preservative) rather than the drug itself. In such cases, preservative-free (MPF) lidocaine is an option. * **Diphenhydramine Limitation:** The main side effect when used as a local anesthetic is skin necrosis or sedation if absorbed systemically in large doses.
Explanation: **Explanation:** Systemic absorption of local anesthetics (LAs) like lidocaine primarily affects the Central Nervous System (CNS) and the Cardiovascular System (CVS) due to the blockade of sodium channels in these excitable tissues. **Why Option A is the Correct Answer:** Lidocaine actually **decreases gastric motility** and slows down intestinal transit. Systemic lidocaine is sometimes used intravenously to treat postoperative ileus because it has anti-inflammatory properties, but its direct effect on the smooth muscles of the gastrointestinal tract is inhibitory, not stimulatory. Therefore, "increased gastric motility" is not a side effect of lidocaine toxicity. **Analysis of Incorrect Options:** * **B. Tonic-clonic convulsions:** This is a classic sign of CNS toxicity. LAs initially inhibit inhibitory pathways in the brain, leading to excitatory symptoms like tremors and seizures (tonic-clonic). * **C. Decreased cardiac output:** At high systemic concentrations, lidocaine blocks sodium channels in the myocardium, leading to negative inotropy (decreased contractility), bradycardia, and eventually a drop in cardiac output. * **D. Respiratory depression:** As toxicity progresses, the initial CNS excitation is followed by generalized CNS depression. This leads to the depression of the medullary respiratory centers, resulting in apnea or respiratory arrest. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Toxicity:** CNS symptoms (tinnitus, perioral numbness, seizures) usually precede CVS symptoms (arrhythmias, hypotension). * **Bupivacaine vs. Lidocaine:** Bupivacaine is significantly more cardiotoxic than lidocaine. * **Antidote:** Intravenous **Lipid Emulsion (Intralipid 20%)** is the specific treatment for Local Anesthetic Systemic Toxicity (LAST).
Chemistry and Mechanism of Action
Practice Questions
Pharmacokinetics of Local Anesthetics
Practice Questions
Amide Local Anesthetics
Practice Questions
Ester Local Anesthetics
Practice Questions
Clinical Uses of Local Anesthetics
Practice Questions
Toxicity of Local Anesthetics
Practice Questions
Management of Local Anesthetic Systemic Toxicity
Practice Questions
Adjuvants to Local Anesthetics
Practice Questions
Maximum Safe Doses
Practice Questions
Local Anesthetics in Special Populations
Practice Questions
Allergic Reactions to Local Anesthetics
Practice Questions
Future Developments in Local Anesthetics
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free